CITIUS PHARMAC (Germany) Top Insiders

47N Stock  EUR 3.29  0.00  0.00%   
Examination of CITIUS PHARMAC's management performance can provide insight into the company performance.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CITIUS PHARMAC DL. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Symbol  47N
Name  CITIUS PHARMAC DL
TypeStock
Country  
 Germany
Exchange  F

Information on CITIUS PHARMAC DL Leadership is currently not available.

If you believe this information is not accurate please let us know and we will check it out. Check all delisted instruments across multiple markets.

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

CITIUS PHARMAC Management Team Effectiveness

The company has return on total asset (ROA) of (0.1624) % which means that it has lost $0.1624 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.2848) %, meaning that it generated substantial loss on money invested by shareholders. CITIUS PHARMAC's management efficiency ratios could be used to measure how well CITIUS PHARMAC manages its routine affairs as well as how well it operates its assets and liabilities.

CITIUS PHARMAC Workforce Comparison

CITIUS PHARMAC DL is number one stock in number of employees category among its peers. The total workforce of Biotechnology industry is presently estimated at about 74,267. CITIUS PHARMAC adds roughly 21.0 in number of employees claiming only tiny portion of stocks in Biotechnology industry.

CITIUS PHARMAC DL Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. CITIUS PHARMAC DL Price Series Summation is a cross summation of CITIUS PHARMAC price series and its benchmark/peer.

About CITIUS PHARMAC Management Performance

The success or failure of an entity such as CITIUS PHARMAC DL often depends on how effective the management is. CITIUS PHARMAC management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of CITIUS management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the CITIUS management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes critical care products targeting medical needs with a focus on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey. CITIUS PHARMAC operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 10 people.

Complementary Tools for CITIUS Stock analysis

When running CITIUS PHARMAC's price analysis, check to measure CITIUS PHARMAC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CITIUS PHARMAC is operating at the current time. Most of CITIUS PHARMAC's value examination focuses on studying past and present price action to predict the probability of CITIUS PHARMAC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CITIUS PHARMAC's price. Additionally, you may evaluate how the addition of CITIUS PHARMAC to your portfolios can decrease your overall portfolio volatility.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities